Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Petr Vyšinský"'
Publikováno v:
Chemické listy. 116:746-750
The radiopharmaceutical 68Ga-PSMA-11 represents a radiopharmaceutical drug without marketing authorization for the prostate cancer diagnosis in a specific treatment program. In respect of the radiopharmaceutical technology, the difficultness of the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44dd8815855f256b0dc9bbb9c889949f
https://doi.org/10.54779/chl20220746
https://doi.org/10.54779/chl20220746
Autor:
Michal Budinský, Petr Vyšinský, Stanislav Synek, Beatrix Bencsiková, Iveta Selingerová, Zdeněk Řehák
Publikováno v:
Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti. 70(4)
The radiopharmaceutical 68Ga-DOTATOC represents the latest radiopharmaceutical in the diagnosis of a neuroendocrine tumor with somatostatin receptor overexpression. Technological and economic difficulties of preparing and quality control of the radio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cb7d509f261a43f2e09b00a039dac7d
https://pubmed.ncbi.nlm.nih.gov/35045714
https://pubmed.ncbi.nlm.nih.gov/35045714
Publikováno v:
Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti. 69(5-6)
Preparation of radiopharmaceuticals means everyday exposure to ionizing radiation for pharmaceutical workers. Manual preparation of positron radio-pharmaceuticals may be a risk in exceeding the legisla-tive limits for radiation workers, in particular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::28ebbd0c70d776bf826f4bcf537d35a4
https://pubmed.ncbi.nlm.nih.gov/33736447
https://pubmed.ncbi.nlm.nih.gov/33736447